Antidiabetic Therapy in End‐Stage Renal Disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1525-139x|28|4|337-344

ISSN： 0894-0959

Source： SEMINARS IN DIALYSIS, Vol.28, Iss.4, 2015-07, pp. : 337-344

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bicarbonate Therapy in End‐Stage Renal Disease: Current Practice Trends and Implications

By  

SEMINARS IN DIALYSIS, Vol. 28, Iss. 4, 2015-07 ,pp. : 370-376

John Wiley & Sons Inc

Access to resources Recommend Favorite

QT–interval parameters in end–stage renal disease

By Cardoso C.   Salles G.  

Clinical Autonomic Research, Vol. 14, Iss. 4, 2004-08 ,pp. : 214-216

Springer Publishing Company

Access to resources Recommend Favorite

Optimising Treatment of End-Stage Renal Disease in the Elderly

By  

Nephron Clin Pract, Vol. 124, Iss. 3-4, 2014-01 ,pp. : 202-208

Karger

Access to resources Recommend Favorite

Psychotherapeutic Agents in End‐Stage Renal Disease

By  

SEMINARS IN DIALYSIS, Vol. 28, Iss. 4, 2015-07 ,pp. : 417-426

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antihypertensive Medications in End‐Stage Renal Disease

By  

SEMINARS IN DIALYSIS, Vol. 28, Iss. 4, 2015-07 ,pp. : 330-336

John Wiley & Sons Inc

Access to resources Recommend Favorite